Clinical Trial Update: Safety and Efficacy of ALV003 for the Treatment of Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results show safety and efficacy signals for ALV003 in the treatment of celiac disease. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• ALV003

Snippet

Sponsor: Alvine Pharmaceuticals Inc. | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED